{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:00:33Z","timestamp":1753437633426},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Irving Harris Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1245\/s10434-024-15030-4","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T15:03:03Z","timestamp":1708354983000},"page":"3339-3349","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden Risk"],"prefix":"10.1245","volume":"31","author":[{"given":"Varun V.","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celyn","family":"Bregio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter D. D.","family":"Witmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"IV","given":"Frederick A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaniv","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biren","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane E.","family":"Churpek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Drazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver S.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedy L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran K.","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"issue":"3","key":"15030_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5(3):632\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x.","journal-title":"J Thromb Haemost"},{"issue":"10","key":"15030_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712\u201323. https:\/\/doi.org\/10.1182\/blood-2013-04-460121.","journal-title":"Blood"},{"issue":"12","key":"15030_CR3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","volume":"122","author":"I Pabinger","year":"2013","unstructured":"Pabinger I, Thaler J, Ay C. Biomarkers for prediction of venous thromboembolism in cancer. Blood. 2013;122(12):2011\u20138. https:\/\/doi.org\/10.1182\/blood-2013-04-460147.","journal-title":"Blood"},{"issue":"14","key":"15030_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959\u201369. https:\/\/doi.org\/10.1182\/blood.2020007338.","journal-title":"Blood"},{"issue":"Suppl 1","key":"15030_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0049-3848(20)30389-3","volume":"191","author":"F Moik","year":"2020","unstructured":"Moik F, Ay C, Pabinger I. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future. Thromb Res. 2020;191(Suppl 1):S3\u201311. https:\/\/doi.org\/10.1016\/S0049-3848(20)30389-3.","journal-title":"Thromb Res"},{"issue":"6","key":"15030_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer\u2013a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404\u201313. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.021.","journal-title":"Eur J Cancer"},{"issue":"11","key":"15030_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21037\/atm.2017.03.96","volume":"5","author":"J Kim","year":"2017","unstructured":"Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review. Ann Transl Med. 2017;5(11):236. https:\/\/doi.org\/10.21037\/atm.2017.03.96.","journal-title":"Ann Transl Med"},{"issue":"4","key":"15030_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jtcvs.2009.02.028","volume":"138","author":"A Patel","year":"2009","unstructured":"Patel A, Anraku M, Darling GE, et al. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies. J Thorac Cardiovasc Surg. 2009;138(4):843\u20138. https:\/\/doi.org\/10.1016\/j.jtcvs.2009.02.028.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"15030_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1076029614564861","volume":"22","author":"D Koksal","year":"2016","unstructured":"Koksal D, Safak O, Ozcan A, Agackiran Y, Erturk H, Findik G. Thromboembolic events in malignant pleural mesothelioma. Clin Appl Thromb Hemost. 2016;22(4):390\u20134. https:\/\/doi.org\/10.1177\/1076029614564861.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"15030_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.athoracsur.2007.11.064","volume":"85","author":"D Nguyen","year":"2008","unstructured":"Nguyen D, Lee SJ, Libby E, Verschraegen C. Rate of thromboembolic events in mesothelioma. Ann Thorac Surg. 2008;85(3):1032\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.11.064.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"15030_CR11","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jtcvs.2019.12.115","volume":"160","author":"LE De Le\u00f3n","year":"2020","unstructured":"De Le\u00f3n LE, Bravo-I\u00f1iguez CE, Fox S, et al. Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020;160(4):1064\u201373. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.12.115.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"15030_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jtcvs.2019.12.082","volume":"160","author":"RB Cameron","year":"2020","unstructured":"Cameron RB. Commentary: mesothelioma: the guinness world record holder in thromboembolism. J Thorac Cardiovasc Surg. 2020;160(4):1074\u20135. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.12.082.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"15030_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/JCO.1983.1.6.386","volume":"1","author":"KH Antman","year":"1983","unstructured":"Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1(6):386\u201391. https:\/\/doi.org\/10.1200\/JCO.1983.1.6.386.","journal-title":"J Clin Oncol"},{"issue":"4","key":"15030_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/107602960401000413","volume":"10","author":"M Ozkan","year":"2004","unstructured":"Ozkan M, Eser B, Er O, et al. Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: a case report. Clin Appl Thromb Hemost. 2004;10(4):393\u20136. https:\/\/doi.org\/10.1177\/107602960401000413.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"15030_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00000441-200004000-00013","volume":"319","author":"Y Ust\u00fcnda\u011f","year":"2000","unstructured":"Ust\u00fcnda\u011f Y, Can U, Benli S, B\u00fcy\u00fckasik Y, Ozbek N. Internal carotid artery occlusion in a patient with malignant peritoneal mesothelioma: is it a sign of malignancy-related thrombosis? Am J Med Sci. 2000;319(4):265\u20137. https:\/\/doi.org\/10.1097\/00000441-200004000-00013.","journal-title":"Am J Med Sci"},{"issue":"7","key":"15030_CR16","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1245\/s10434-019-07414-8","volume":"26","author":"S Khan","year":"2019","unstructured":"Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. Incidence, risk factors, and prevention strategies for venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(7):2276\u201384. https:\/\/doi.org\/10.1245\/s10434-019-07414-8.","journal-title":"Ann Surg Oncol"},{"key":"15030_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jss.2017.08.053","volume":"221","author":"JM Baumgartner","year":"2018","unstructured":"Baumgartner JM, McKenzie S, Block S, Costantini TW, Lowy AM. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J Surg Res. 2018;221:183\u20139. https:\/\/doi.org\/10.1016\/j.jss.2017.08.053.","journal-title":"J Surg Res"},{"issue":"1","key":"15030_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/02656736.2020.1742389","volume":"37","author":"M Tuovila","year":"2020","unstructured":"Tuovila M, Erkinaro T, Takala H, et al. Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study. Int J Hyperth. 2020;37(1):293\u2013300. https:\/\/doi.org\/10.1080\/02656736.2020.1742389.","journal-title":"Int J Hyperth"},{"issue":"11","key":"15030_CR19","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1158\/2159-8290.CD-21-0331","volume":"11","author":"K Raghav","year":"2021","unstructured":"Raghav K, Liu S, Overman MJ, et al. Efficacy, safety, and biomarker analysis of combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) blockade in advanced malignant peritoneal mesothelioma. Cancer Discov. 2021;11(11):2738\u201347. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0331.","journal-title":"Cancer Discov"},{"issue":"19","key":"15030_CR20","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1001\/jama.2008.656","volume":"300","author":"SR Nalluri","year":"2008","unstructured":"Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S. Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA. 2008;300(19):2277\u201385. https:\/\/doi.org\/10.1001\/jama.2008.656.","journal-title":"JAMA"},{"key":"15030_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jss.2018.09.022","volume":"234","author":"AZ Paredes","year":"2019","unstructured":"Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM. Predictors of readmission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2019;234:103\u20139. https:\/\/doi.org\/10.1016\/j.jss.2018.09.022.","journal-title":"J Surg Res"},{"issue":"6","key":"15030_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM. STROBE reporting guidelines for observational studies. JAMA Surgery. 2021;156(6):577\u20138. https:\/\/doi.org\/10.1001\/jamasurg.2021.0528.","journal-title":"JAMA Surgery"},{"key":"15030_CR23","unstructured":"Analytics, Insights, & Discovery | Epic. Available at: https:\/\/www.epic.com\/software\/analytics-insights-discovery. Accessed 5 Mar 2023."},{"issue":"36","key":"15030_CR24","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237\u201342. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15030_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1245\/s10434-020-08324-w","volume":"27","author":"D Schuitevoerder","year":"2020","unstructured":"Schuitevoerder D, Izquierdo FJ, Plana A, et al. The Chicago consensus on peritoneal surface malignancies: management of peritoneal mesothelioma. Ann Surg Oncol. 2020;27(6):1774\u20139. https:\/\/doi.org\/10.1245\/s10434-020-08324-w.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"15030_CR26","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","volume":"46","author":"M H\u00fcbner","year":"2020","unstructured":"H\u00fcbner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u2013part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46(12):2292\u2013310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"15030_CR27","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1245\/s10434-021-09973-1","volume":"28","author":"A Dhiman","year":"2021","unstructured":"Dhiman A, Fenton E, Whitridge J, et al. Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for patients undergoing cytoreductive surgery with or without HIPEC. Ann Surg Oncol. 2021;28(12):6955\u201364. https:\/\/doi.org\/10.1245\/s10434-021-09973-1.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"15030_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00384-021-04021-6","volume":"37","author":"M Lundbech","year":"2022","unstructured":"Lundbech M, Krag AE, Iversen LH, Hvas AM. Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(1):17\u201333. https:\/\/doi.org\/10.1007\/s00384-021-04021-6.","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"15030_CR29","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1245\/s10434-021-09941-9","volume":"28","author":"P Dranichnikov","year":"2021","unstructured":"Dranichnikov P, Mahteme H, Cashin PH, Graf W. Coagulopathy and venous thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2021;28(12):7772\u201382. https:\/\/doi.org\/10.1245\/s10434-021-09941-9.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"15030_CR30","first-page":"18","volume":"52","author":"K Lanuke","year":"2009","unstructured":"Lanuke K, Mack LA, Temple WJ. A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Can J Surg. 2009;52(1):18\u201322.","journal-title":"Can J Surg"},{"issue":"35","key":"15030_CR31","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","volume":"30","author":"S Seng","year":"2012","unstructured":"Seng S, Liu Z, Chiu SK, et al. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol. 2012;30(35):4416\u201326. https:\/\/doi.org\/10.1200\/JCO.2012.42.4358.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15030_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/bjc.1998.150","volume":"77","author":"T Nakano","year":"1998","unstructured":"Nakano T, Chahinian AP, Shinjo M, et al. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer. 1998;77(6):907\u201312.","journal-title":"Br J Cancer"},{"issue":"7","key":"15030_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/jso.24746","volume":"116","author":"A Rottenstreich","year":"2017","unstructured":"Rottenstreich A, Kalish Y, Kleinstern G, Yaacov AB, Dux J, Nissan A. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(7):914\u201320. https:\/\/doi.org\/10.1002\/jso.24746.","journal-title":"J Surg Oncol"},{"issue":"3","key":"15030_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ygyno.2015.07.005","volume":"138","author":"B Ataseven","year":"2015","unstructured":"Ataseven B, du Bois A, Reinthaller A, et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015;138(3):560\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2015.07.005.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"15030_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1160\/TH09-12-0856","volume":"104","author":"AR Folsom","year":"2010","unstructured":"Folsom AR, Lutsey PL, Heckbert SR, Cushman M. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010;104(1):100\u20134. https:\/\/doi.org\/10.1160\/TH09-12-0856.","journal-title":"Thromb Haemost"},{"issue":"2","key":"15030_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1634\/theoncologist.2015-0284","volume":"21","author":"O K\u00f6nigsbr\u00fcgge","year":"2016","unstructured":"K\u00f6nigsbr\u00fcgge O, Posch F, Riedl J, et al. Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients. Oncologist. 2016;21(2):252\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2015-0284.","journal-title":"Oncologist"},{"issue":"2","key":"15030_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1160\/TH05-04-0266","volume":"94","author":"EA Fox","year":"2005","unstructured":"Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005;94(2):362\u20135. https:\/\/doi.org\/10.1160\/TH05-04-0266.","journal-title":"Thromb Haemost"},{"issue":"6","key":"15030_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.20524\/aog.2018.0305","volume":"31","author":"S Boussios","year":"2018","unstructured":"Boussios S, Moschetta M, Karathanasi A, et al. Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives. Ann Gastroenterol. 2018;31(6):659\u201369. https:\/\/doi.org\/10.20524\/aog.2018.0305.","journal-title":"Ann Gastroenterol"},{"issue":"13","key":"15030_CR39","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","volume":"130","author":"Y Hisada","year":"2017","unstructured":"Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017;130(13):1499\u2013506. https:\/\/doi.org\/10.1182\/blood-2017-03-743211.","journal-title":"Blood"},{"issue":"3","key":"15030_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.seminoncol.2014.04.009","volume":"41","author":"GC Connolly","year":"2014","unstructured":"Connolly GC, Phipps RP, Francis CW. Platelets and cancer-associated thrombosis. Semin Oncol. 2014;41(3):302\u201310. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.04.009.","journal-title":"Semin Oncol"},{"issue":"3","key":"15030_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jtcvs.2005.10.027","volume":"131","author":"DP Mason","year":"2006","unstructured":"Mason DP, Quader MA, Blackstone EH, et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg. 2006;131(3):711\u20138. https:\/\/doi.org\/10.1016\/j.jtcvs.2005.10.027.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"25","key":"15030_CR42","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846\u201350. https:\/\/doi.org\/10.1056\/NEJM200012213432504.","journal-title":"N Engl J Med"},{"key":"15030_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/CMAR.S47094","volume":"5","author":"MH Amer","year":"2013","unstructured":"Amer MH. Cancer-associated thrombosis: clinical presentation and survival. Cancer Manag Res. 2013;5:165\u201378. https:\/\/doi.org\/10.2147\/CMAR.S47094.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"15030_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ygyno.2007.05.040","volume":"107","author":"D Black","year":"2007","unstructured":"Black D, Iasonos A, Ahmed H, Chi DS, Barakat RR, Abu-Rustum NR. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. Gynecol Oncol. 2007;107(1):66\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2007.05.040.","journal-title":"Gynecol Oncol"},{"key":"15030_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.xjon.2021.02.011","volume":"6","author":"GG Akhtar-Danesh","year":"2021","unstructured":"Akhtar-Danesh GG, Ben-Avi R, Agzarian J, Shargall Y. Is asymptomatic postoperative venous thromboembolism associated with long-term survival in patients undergoing lung resection for malignancy? JTCVS Open. 2021;6:241\u20135. https:\/\/doi.org\/10.1016\/j.xjon.2021.02.011.","journal-title":"JTCVS Open"},{"issue":"23","key":"15030_CR46","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","volume":"3","author":"DR Anderson","year":"2019","unstructured":"Anderson DR, Morgano GP, Bennett C, et al. American society of hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898\u2013944. https:\/\/doi.org\/10.1182\/bloodadvances.2019000975.","journal-title":"Blood Adv"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15030-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15030-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15030-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:09:34Z","timestamp":1712333374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15030-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["15030"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15030-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,19]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jane E. Churpek has received grants from the Department of Defense, and honoraria from UpToDate, Inc. Michael W. Drazer has received personal fees from Cardinal Health Consulting and Argenx Consulting. Oliver S. Eng is a speaker for Tempus Labs. Hedy L. Kindler has received nonfinancial support from AstraZeneca, and personal fees from Tempus, Bluestar Genomics, Sanofi, Opna, AstraZeneca, Deciphera, Seageb, and Novocure. Kiran K. Turaga has received speaking fees from Aspire Bariatrics, and is a consultant for Merck. Frederick A. Godley has received a grant from Intuitive Surgical for unrelated work focused on education, in a surgical video. Varun V. Bansal, Owen Mitchell, Celyn Bregio, Hunter D.D. Witmer, Ankit Dhiman, Cecilia Ong, Yaniv Berger, and Biren Reddy have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This study was approved by the IRB of the University of Chicago.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The patients included in this study consented to participate in an IRB-approved mesothelioma registry at the University of Chicago.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent"}}]}}